1-16 of 16
Authors: Keiran Smalley
Save search
Sort by
Journal Article

TIPS-04 A RANDOMIZED, MULTI-INSTITUTIONAL PILOT STUDY TO EVALUATE THE MOLECULAR AND CELLULAR RESPONSE TO TREATMENT WITH NIVOLUMAB WITH EITHER ADJUVANT IPILIMUMAB OR RELATLIMAB IN ADULT PATIENTS WITH SURGICALLY RESECTABLE MELANOMA BRAIN METASTASES: ONGOING TRIAL Open Access

PDF
Yolanda Pina and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii34, https://doi.org/10.1093/noajnl/vdad070.135
Published: 04 August 2023
Journal Article

SYST-03 PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD) FROM EPITHELIAL CARCINOMAS: FINAL RESULTS AND MOLECULAR ANALYSES WITH SINGLE CELL RNA SEQUENCING Open Access

PDF
Yolanda Pina and others
Neuro-Oncology Advances, Volume 5, Issue Supplement_3, August 2023, Page iii28, https://doi.org/10.1093/noajnl/vdad070.111
Published: 04 August 2023
Journal Article

CTIM-01. TITLE: PHASE 1B STUDY OF AVELUMAB AND WHOLE BRAIN RADIOTHERAPY (WBRT) IN PATIENTS WITH LEPTOMENINGEAL DISEASE (LMD): PRELIMINARY RESULTS Free

PDF
Yolanda Pina and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii59, https://doi.org/10.1093/neuonc/noac209.233
Published: 14 November 2022
Journal Article

BIOM-02. LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA: UPDATES ON THE VALIDITY OF THE VERIDEX CELLSEARCH SYSTEM Free

PDF
yolanda Pina and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi10, https://doi.org/10.1093/neuonc/noab196.034
Published: 12 November 2021
Journal Article

LMD-03. Single cell analysis reveals how therapy remodels the tumor microenvironment in melanoma CNS metastases and uncovers a novel predictor of improved survival Open Access

PDF
Inna Smalley and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Pages iii7–iii8, https://doi.org/10.1093/noajnl/vdab071.028
Published: 09 August 2021
Journal Article

LMD-05. Phase 1B Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD): Preliminary Results Open Access

PDF
Yolanda Pina and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Page iii8, https://doi.org/10.1093/noajnl/vdab071.030
Published: 09 August 2021
Journal Article

LMD-07. In Vitro AND In Vivo Culture of Patient Derived-Cerebral Spinal Fluid-Circulating Tumor Cells (PD-CSF-CTCs) in Leptomeningeal Disease (LMD) From Melanoma to Identify Novel Treatment Strategies Open Access

PDF
Vincent Law and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Page iii8, https://doi.org/10.1093/noajnl/vdab071.032
Published: 09 August 2021
Journal Article

OTME-17. Single cell characterization of the immune microenvironment of melanoma brain and leptomeningeal metastases Open Access

PDF
Inna Smalley and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_2, July 2021, Page ii17, https://doi.org/10.1093/noajnl/vdab070.068
Published: 05 July 2021
Journal Article

TMOD-02. IN VITRO & IN VIVO CULTURE OF PATIENT DERIVED (PD) CSF-CTCS IN LEPTOMENINGEAL DISEASE (LMD) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES Free

PDF
Vincent Law and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii227–ii228, https://doi.org/10.1093/neuonc/noaa215.953
Published: 09 November 2020
Journal Article

23. RETROSPECTIVE REVIEW OF ADULT PATIENTS WITH LEPTOMENINGEAL DISEASE SECONDARY TO MELANOMA AT MOFFITT CANCER CENTER: DIAGNOSIS, TREATMENT AND OUTCOMES Open Access

PDF
Yolanda Pina and others
Neuro-Oncology Advances, Volume 2, Issue Supplement_2, August 2020, Page ii4, https://doi.org/10.1093/noajnl/vdaa073.013
Published: 04 August 2020
Journal Article

CMET-26. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCS IN LEPTOMENINGEAL DISEASE (LMDZ) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES Free

PDF
Vincent Law and others
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Page vi57, https://doi.org/10.1093/neuonc/noz175.227
Published: 11 November 2019
Journal Article

LPTO-03. IN-VITRO & IN-VIVO CULTURE OF PATIENT (PT) DERIVED CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM MELANOMA TO IDENTIFY NOVEL TREATMENT STRATEGIES Open Access

PDF
Vincent Law and others
Neuro-Oncology Advances, Volume 1, Issue Supplement_1, August 2019, Pages i6–i7, https://doi.org/10.1093/noajnl/vdz014.026
Published: 12 August 2019
Journal Article

EXTH-39. DETECTION, MOLECULAR PROFILING AND CULTURE OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) IN MELANOMA TO IMPROVE DIAGNOSIS AND TREATMENT STRATEGIES Free

PDF
Vincent Law and others
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi93, https://doi.org/10.1093/neuonc/noy148.387
Published: 05 November 2018
Journal Article

CMET-36. DETECTION, MOLECULAR PROFILING AND CULTURE OF CSF-CTCS IN LEPTOMENINGEAL DISEASE (LMDz) IN MELANOMA Free

PDF
Brittany Evernden and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi46, https://doi.org/10.1093/neuonc/nox168.183
Published: 06 November 2017
Journal Article

RARE-18. DETECTION, MOLECULAR PROFILING AND CULTURE OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) IN MELANOMA Free

PDF
Brittany Evernden and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Pages vi163–vi164, https://doi.org/10.1093/neuonc/now212.681
Published: 07 November 2016
Journal Article

RARE-34. DIAGNOSIS AND MOLECULAR CHARACTERIZATION OF CSF-CTCs IN LEPTOMENINGEAL DISEASE (LMDz) FROM UVEAL MELANOMA (UM) Free

PDF
Inna Fedorenko and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi167, https://doi.org/10.1093/neuonc/now212.697
Published: 07 November 2016